Origen de la red de primer grado Steve Daly.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Abvance Therapeutics, Inc.
 Abvance Therapeutics, Inc. BiotechnologyHealth Technology Abvance Therapeutics, Inc. is a pharmaceutical company that aims to improve diabetes control and reduce the risk of hypoglycemia. The company is based in Reno, NV. The company's Abv100 platform is designed to replace rapid acting insulin and can be used by any patient type, including those with type 1 and type 2 diabetes who use injections or pumps. The platform protects against hypoglycemia, allowing for safer use of insulin and better control of diabetes, which can lead to improved long-term health outcomes. The company was founded in 2016 by Alan Cherrington, David Maggs, and Soumitra Ghosh. David Maggs has been the CEO since 2016.
1
| Holding Company | Biotechnology | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Steve Daly a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of London | College/University | Doctorate Degree | |
| GI DYNAMICS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Parke, Davis & Co. LLC | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| David Maggs | 5 |
- Bolsa de valores
- Insiders
- Steve Daly
- Conexiones Empresas
